Commissioners are seeking an injunction to shut down BioLab and damages for residents and businesses affected by the fire on ...

Bio-Techne Corporation TECH is set to release its first-quarter fiscal 2025 results on Oct. 30, before the opening bell. The ...

The Pakistan Stock Exchange (PSX) held a gong ceremony to celebrate the listing of BF Biosciences Limited (BFBIO). BFBIO is a ...

Read on to see which sites earned our top rankings, as well as advice about what to look for when it comes to online dating, ...

Sustainable speciality chemicals provider Archroma has introduced the NTR Printing System, which it claims is the first ...

Nuvation Bio's Taletrectinib shows promising data in phase 2 trials for ROS1-positive NSCLC. Find out my recommendation on ...

The global ESD (Electrostatic Discharge) divider market is forecast to witness significant growth over the next decade, with ...

Dozens of volunteer carpenters set up shop in the parking lot of the Prime Meridian Bank on Timberlane Road. There was a big ...

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...

Drugmakers and insurers are exploring different payment schemes for expensive, potentially curative treatments, particularly ones tied to patient response.

Therefore, Belite Bio is evaluating safety and efficacy of Tinlarebant in GA patients in a 2-year Phase 3 study (PHOENIX). Belite Bio is a clinical-stage biopharmaceutical drug development company ...